| P50 | author | Jorge Barriuso | Q57940715 |
| P2093 | author name string | Daniel Castellano | |
| | Enrique Grande | |
| | Jaume Capdevila | |
| | Luis Antón-Aparicio | |
| P2860 | cites work | Cancerous stem cells can arise from pediatric brain tumors | Q24569653 |
| | Modes of resistance to anti-angiogenic therapy | Q24608005 |
| | Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer | Q27851560 |
| | A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 |
| | Minireview: Development and differentiation of gut endocrine cells | Q28252764 |
| | Gastroenteropancreatic neuroendocrine tumours | Q28263732 |
| | Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer | Q28274188 |
| | A tumorigenic subpopulation with stem cell properties in melanomas | Q28277490 |
| | Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q28285545 |
| | Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 |
| | Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells | Q28302950 |
| | Prospective identification of tumorigenic prostate cancer stem cells | Q29547859 |
| | Targeting Hedgehog--a cancer stem cell pathway | Q33925257 |
| | Programming of the pancreas | Q34460457 |
| | Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation | Q34714310 |
| | Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. | Q35023367 |
| | Stem cells in normal breast development and breast cancer | Q35548236 |
| | Site-specific epithelial-mesenchymal interactions in digestive neuroendocrine tumors. An experimental in vivo and in vitro study | Q35745461 |
| | Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors | Q36284221 |
| | Stem cells and cancer | Q36500723 |
| | Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer | Q36516410 |
| | A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas | Q36611857 |
| | Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. | Q36830585 |
| | Controversies in cancer stem cells: targeting embryonic signaling pathways | Q37552660 |
| | Epithelial-mesenchymal transition in cancer development and its clinical significance | Q37644546 |
| | Targeting Notch to target cancer stem cells. | Q37763414 |
| | Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 |
| | Understanding the cancer stem cell. | Q37776152 |
| | Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways | Q37820099 |
| | Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling | Q38442944 |
| | Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum | Q40072380 |
| | Identification and characterization of tumorigenic liver cancer stem/progenitor cells | Q40119609 |
| | Sonic Hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine carcinomas | Q40208886 |
| | Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor | Q44375007 |
| | Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b | Q46716129 |
| | Neuroendocrine tumor epidemiology: contrasting Norway and North America. | Q46944550 |
| | The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids | Q47369132 |
| | What is the developmental fate of the neural crest cells which migrate into the pancreas in the avian embryo? | Q52306224 |
| | Tumorigenic and metastatic activity of human thyroid cancer stem cells. | Q53294256 |
| | Notch signaling: a mediator of beta-cell de-differentiation in diabetes? | Q53645021 |
| | Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor. | Q54454714 |
| | Cancer: Tumour stem cells switch sides. | Q55463595 |
| P433 | issue | 1-2 | |
| P921 | main subject | neoplastic stem cells | Q1638475 |
| | neuroendocrine tumor | Q1981276 |
| P304 | page(s) | 47-53 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Cancer and Metastasis Reviews | Q2647982 |
| P1476 | title | Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist? | |
| P478 | volume | 31 | |